D.F. Torgerson Discovery Award: CNL’s Good Laboratory Practice (GLP) Leads To GLP Full Recognition

Awarded to: Afshan Sahar, Ahmed Soliman, Amanda Adams, Amy Festarini, Ashok Jadhov, Bobbi-Lynn Connell, Christie Costello, Colleen Corris, Dennis Deng, Farihah Gulam, Gail Gayda, Geetika Sharma, George Baidoo, Isabelle Gosselin, Jais Kavumkal, Jen Sparling, Jocelyn Virgin, John Tracey, Lindsey Bertrand, Lisa Carty, Mandy Serran, Marilyne Stuart, Marlene Kontcho, Matt Flegal, Phillip Shreeves, Sarah Arsenault, Sarah Wentzell, Sridhar Devalla, and Viviane Radford

For Outstanding Dedication To The Completion Of CNL’s First Two Good Laboratory Practice (GLP) Studies Leading To GLP Full Recognition

CNL has been working towards full GLP accreditation for several years. The GLP standards have strict rules regarding procedures, equipment, environmental parameters, and product tracing within any GLP facility; all of which require accompanying documentation. Work done following GLP at a GLP-accredited facility allows safety testing of medications for submission and review by regulatory agencies (like the Food and Drug Administration – FDA). A GLP regulatory study is a critical step required to allow a novel drug to progress to human clinical trials. Pre-clinical regulatory studies are vital to advancement of human health, and the health of Canadians. After an intense effort, the team first brought the Biological Research Facility (BRF) quality standards up to ISO 9001, then to the Organization for Economic Co-operation and Development (OECD) GLP standards. By 2021, the GLP program was fully implemented. The Standards Council of Canada (SCC) conducted a formal inspection to assess the facility’s compliance with GLP regulations and CNL received facility accreditation. The final step to becoming fully recognized and accredited for GLP work, was the completion of two commercially-funded GLP animal research studies.